ONCONETIX, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1116 USD | +0.36% |
|
-0.27% | -43.64% |
| Apr. 11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 13 | Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 17.02 | 3.64 |
| Enterprise Value (EV) 1 | -8.73 | 8.972 |
| P/E ratio | -1 x | -0.09 x |
| Yield | - | - |
| Capitalization / Revenue | - | 62,267,904 x |
| EV / Revenue | - | 153,458,137 x |
| EV / EBITDA | 0.66 x | -0.57 x |
| EV / FCF | 2,612,011 x | -557,727 x |
| FCF Yield | 0% | -0% |
| Price to Book | 0.75 x | -0.79 x |
| Nbr of stocks (in thousands) | 15,475 | 18,386 |
| Reference price 2 | 1.100 | 0.1980 |
| Announcement Date | 3/9/23 | 4/11/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales | - | - | - | - | 0.0585 |
| EBITDA 1 | -0.8797 | -1.619 | -3.412 | -13.17 | -15.84 |
| EBIT 1 | -0.8802 | -1.622 | -3.417 | -13.18 | -15.88 |
| Operating Margin | - | - | - | - | -27,161.94% |
| Earnings before Tax (EBT) 1 | -0.8219 | -1.599 | -3.417 | -13.42 | -37.42 |
| Net income 1 | -0.8219 | -1.599 | -3.417 | -13.42 | -37.41 |
| Net margin | - | - | - | - | -63,986.48% |
| EPS 2 | -0.3443 | -0.6748 | -1.264 | -1.101 | -2.186 |
| Free Cash Flow | - | -0.9741 | -1.29 | -3.342 | -16.09 |
| FCF margin | - | - | - | - | -27,514.9% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 10/8/21 | 10/8/21 | 3/31/22 | 3/9/23 | 4/11/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | - |
| EBITDA | - | - | - | - |
| EBIT 1 | -3.246 | -2.848 | -6.65 | -4.488 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | -3.218 | -2.847 | -6.865 | -5.347 |
| Net income 1 | -3.218 | -2.847 | -6.865 | -5.347 |
| Net margin | - | - | - | - |
| EPS 2 | -0.1600 | -0.1800 | -0.4300 | -0.3100 |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/9/23 | 5/12/23 | 10/20/23 | 11/17/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 5.33 |
| Net Cash position 1 | 6.05 | 4.31 | 1.93 | 25.8 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.3367 x |
| Free Cash Flow | - | -0.97 | -1.29 | -3.34 | -16.1 |
| ROE (net income / shareholders' equity) | - | -29.8% | -111% | -113% | -314% |
| ROA (Net income/ Total Assets) | - | -18.6% | -54.1% | -56.1% | -17.4% |
| Assets 1 | - | 8.593 | 6.317 | 23.94 | 214.5 |
| Book Value Per Share 2 | 1.870 | 1.480 | 0.4500 | 1.470 | -0.2500 |
| Cash Flow per Share 2 | 1.890 | 1.350 | 0.6000 | 1.690 | 0.2000 |
| Capex 1 | 0 | 0.01 | 0 | 0.01 | 9.58 |
| Capex / Sales | - | - | - | - | 16,391.12% |
| Announcement Date | 10/8/21 | 10/8/21 | 3/31/22 | 3/9/23 | 4/11/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -43.64% | 3.15M | |
| -2.32% | 92.59B | |
| +3.16% | 41.43B | |
| -11.10% | 33.49B | |
| +53.61% | 25.06B | |
| -9.41% | 12.77B | |
| -12.25% | 11.58B | |
| -44.00% | 11.35B | |
| +5.77% | 8.97B | |
| -6.43% | 8.3B |
- Stock Market
- Equities
- ONCO Stock
- Financials Onconetix, Inc.
